• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis

tetano

Editor, Senior Moderator
J Infect. 2020 Apr 10. pii: S0163-4453(20)30170-5. doi: 10.1016/j.jinf.2020.03.041. [Epub ahead of print]
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis.


Fu L[SUP]1[/SUP], Wang B[SUP]2[/SUP], Yuan T[SUP]1[/SUP], Chen X[SUP]3[/SUP], Ao Y[SUP]3[/SUP], Fitzpatrick T[SUP]4[/SUP], Li P[SUP]1[/SUP], Zhou Y[SUP]1[/SUP], Lin Y[SUP]5[/SUP], Duan Q[SUP]6[/SUP], Luo G[SUP]1[/SUP], Fan S[SUP]7[/SUP], Lu Y[SUP]7[/SUP], Feng A[SUP]1[/SUP], Zhan Y[SUP]1[/SUP], Liang B[SUP]1[/SUP], Cai W[SUP]3[/SUP], Zhang L[SUP]8[/SUP], Du X[SUP]1[/SUP], Shu Y[SUP]9[/SUP], Li L[SUP]10[/SUP], Zou H[SUP]11[/SUP].

Author information




Abstract

OBJECTIVE:

To better inform efforts to treat and control the current outbreak with a comprehensive characterization of COVID-19.
METHODS:

We searched PubMed, EMBASE, Web of Science, and CNKI (Chinese Database) for studies published as of March 2, 2020, and we searched references of identified articles. Studies were reviewed for methodological quality. A random-effects model was used to pool results. Heterogeneity was assessed using I[SUP]2[/SUP]. Publication bias was assessed using Egger's test.
RESULTS:

43 studies involving 3600 patients were included. Among COVID-19 patients, fever (83.3% [95% CI 78.4-87.7]), cough (60.3% [54.2-66.3]), and fatigue (38.0% [29.8-46.5]) were the most common clinical symptoms. The most common laboratory abnormalities were elevated C-reactive protein (68.6% [58.2-78.2]), decreased lymphocyte count (57.4% [44.8-69.5]) and increased lactate dehydrogenase (51.6% [31.4-71.6]). Ground-glass opacities (80.0% [67.3-90.4]) and bilateral pneumonia (73.2% [63.4-82.1]) were the most frequently reported findings on computed tomography. The overall estimated proportion of severe cases and case-fatality rate (CFR) was 25.6% (17.4-34.9) and 3.6% (1.1-7.2), respectively. CFR and laboratory abnormalities were higher in severe cases, patients from Wuhan, and older patients, but CFR did not differ by gender.
CONCLUSIONS:

The majority of COVID-19 cases are symptomatic with a moderate CFR. Patients living in Wuhan, older patients, and those with medical comorbidities tend to have more severe clinical symptoms and higher CFR.
Copyright ? 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.



KEYWORDS:

COVID-19; clinical characteristics; meta-analysis; systematic review


PMID:32283155DOI:10.1016/j.jinf.2020.03.041
 
Back
Top Bottom